BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
9.48
-0.21 (-2.17%)
At close: Aug 21, 2026, 4:00 PM EDT
9.75
+0.27 (2.85%)
After-hours: Aug 21, 2026, 7:34 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $435.1 million as of August 21, 2026. Its market cap has increased by 173.35% in one year.
Market Cap
435.10M
Enterprise Value
56.67M
1-Year Change
173.35%
Ranking
Category
Stock Price
$9.48
ChartMarket Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $435.10M, a decrease of -29.25%. That is a compound annual growth rate of -16.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 435.10M | -8.28% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 708.88M |
| Evotec SE | 696.39M |
| Tilray Brands | 656.37M |
| Aquestive Therapeutics | 584.88M |
| Evolus | 554.16M |
| Kamada | 465.10M |
| Canopy Growth | 448.57M |
| Alpha Teknova | 395.15M |